AU4990696A
(en)
*
|
1995-02-24 |
1996-09-11 |
Nanosystems L.L.C. |
Aerosols containing nanoparticle dispersions
|
US6143211A
(en)
*
|
1995-07-21 |
2000-11-07 |
Brown University Foundation |
Process for preparing microparticles through phase inversion phenomena
|
EP0855906B1
(de)
*
|
1995-10-17 |
2008-02-20 |
Jagotec AG |
Verabreichung unlöslicher arzneistoffe
|
US5858401A
(en)
|
1996-01-22 |
1999-01-12 |
Sidmak Laboratories, Inc. |
Pharmaceutical composition for cyclosporines
|
US6465016B2
(en)
*
|
1996-08-22 |
2002-10-15 |
Research Triangle Pharmaceuticals |
Cyclosporiine particles
|
US7255877B2
(en)
*
|
1996-08-22 |
2007-08-14 |
Jagotec Ag |
Fenofibrate microparticles
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
EP1067914B1
(de)
*
|
1998-03-30 |
2006-02-22 |
Jagotec Ag |
Zubereitungen enthaltend mikropartikel von wasserunlöslichen substanzen, sowie verfahren zu deren herstellung
|
US6337092B1
(en)
|
1998-03-30 |
2002-01-08 |
Rtp Pharma Inc. |
Composition and method of preparing microparticles of water-insoluble substances
|
CA2333648C
(en)
|
1998-05-29 |
2008-10-21 |
Rtp Pharma Inc. |
Thermoprotected microparticle compositions and process for terminal steam sterilization thereof
|
AU755993C
(en)
|
1998-06-19 |
2003-10-30 |
Skyepharma Canada Inc. |
Processes to generate submicron particles of water-insoluble compounds
|
US6551613B1
(en)
*
|
1998-09-08 |
2003-04-22 |
Alza Corporation |
Dosage form comprising therapeutic formulation
|
US20040013613A1
(en)
*
|
2001-05-18 |
2004-01-22 |
Jain Rajeev A |
Rapidly disintegrating solid oral dosage form
|
EP2266542A3
(de)
*
|
1998-10-01 |
2013-07-31 |
Elan Pharma International Limited |
Nanopartikelformulierungen mit kontrollierter Wirkstofffreisetzung
|
US8236352B2
(en)
*
|
1998-10-01 |
2012-08-07 |
Alkermes Pharma Ireland Limited |
Glipizide compositions
|
US20090297602A1
(en)
*
|
1998-11-02 |
2009-12-03 |
Devane John G |
Modified Release Loxoprofen Compositions
|
US7521068B2
(en)
*
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
US6428814B1
(en)
|
1999-10-08 |
2002-08-06 |
Elan Pharma International Ltd. |
Bioadhesive nanoparticulate compositions having cationic surface stabilizers
|
US6969529B2
(en)
|
2000-09-21 |
2005-11-29 |
Elan Pharma International Ltd. |
Nanoparticulate compositions comprising copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers
|
CN1287769C
(zh)
*
|
1998-11-20 |
2006-12-06 |
斯凯伊药品加拿大公司 |
可分散的磷脂稳定的微粒
|
KR20010075713A
(ko)
*
|
1998-11-20 |
2001-08-09 |
추후제출 |
불용성 마이크로입자의 안정된 현탁액의 제조방법
|
US6251886B1
(en)
|
1998-12-07 |
2001-06-26 |
Schering Corporation |
Methods of using temozolomide in the treatment of cancers
|
TR200101790T2
(tr)
|
1998-12-23 |
2001-10-22 |
Idea Ag. |
Yayılgan olmayan in vivo topik uygulamalar için geliştirilmiş formül
|
US7374779B2
(en)
*
|
1999-02-26 |
2008-05-20 |
Lipocine, Inc. |
Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
|
US20030236236A1
(en)
*
|
1999-06-30 |
2003-12-25 |
Feng-Jing Chen |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
DE19932157A1
(de)
*
|
1999-07-13 |
2001-01-18 |
Pharmasol Gmbh |
Verfahren zur schonenden Herstellung von hochfeinen Mikropartikeln und Nanopartikeln
|
US6656504B1
(en)
|
1999-09-09 |
2003-12-02 |
Elan Pharma International Ltd. |
Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
|
ATE296091T1
(de)
*
|
1999-09-21 |
2005-06-15 |
Skyepharma Canada Inc |
Oberflächenmodifizierte teilchenförmige zusammensetzungen biologisch aktiver stoffe
|
US7732404B2
(en)
*
|
1999-12-30 |
2010-06-08 |
Dexcel Ltd |
Pro-nanodispersion for the delivery of cyclosporin
|
WO2001080828A2
(en)
|
2000-04-20 |
2001-11-01 |
Rtp Pharma Inc. |
Improved water-insoluble drug particle process
|
ATE389455T1
(de)
|
2000-05-10 |
2008-04-15 |
Jagotec Ag |
Zerkleinerung mittels mahlkörper
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
ATE424811T1
(de)
|
2000-08-31 |
2009-03-15 |
Jagotec Ag |
Gemahlene partikel
|
US20020058065A1
(en)
*
|
2000-09-20 |
2002-05-16 |
Pol-Henri Guivarc'h |
Insoluble drug particle compositions with improved fasted-fed effects
|
AU2001262945B2
(en)
*
|
2000-09-20 |
2006-02-02 |
Skyepharma Canada Inc. |
Spray drying process and compositions of fenofibrate
|
US8586094B2
(en)
|
2000-09-20 |
2013-11-19 |
Jagotec Ag |
Coated tablets
|
US7198795B2
(en)
|
2000-09-21 |
2007-04-03 |
Elan Pharma International Ltd. |
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
|
US7998507B2
(en)
|
2000-09-21 |
2011-08-16 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors
|
JP4541647B2
(ja)
*
|
2000-11-20 |
2010-09-08 |
エラン ファーマ インターナショナル,リミティド |
表面安定剤として共重合体を含むナノ粒子組成物
|
EP1216713A1
(de)
*
|
2000-12-20 |
2002-06-26 |
Schering Aktiengesellschaft |
Zusammensetzungen von Estrogen-Zyklodextrin Komplexe
|
US6951656B2
(en)
*
|
2000-12-22 |
2005-10-04 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US8067032B2
(en)
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
US20030096013A1
(en)
*
|
2000-12-22 |
2003-05-22 |
Jane Werling |
Preparation of submicron sized particles with polymorph control
|
US6884436B2
(en)
*
|
2000-12-22 |
2005-04-26 |
Baxter International Inc. |
Method for preparing submicron particle suspensions
|
US6977085B2
(en)
*
|
2000-12-22 |
2005-12-20 |
Baxter International Inc. |
Method for preparing submicron suspensions with polymorph control
|
US20040256749A1
(en)
*
|
2000-12-22 |
2004-12-23 |
Mahesh Chaubal |
Process for production of essentially solvent-free small particles
|
US6607784B2
(en)
*
|
2000-12-22 |
2003-08-19 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US7193084B2
(en)
*
|
2000-12-22 |
2007-03-20 |
Baxter International Inc. |
Polymorphic form of itraconazole
|
US9700866B2
(en)
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
US20050048126A1
(en)
*
|
2000-12-22 |
2005-03-03 |
Barrett Rabinow |
Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
|
US6534088B2
(en)
*
|
2001-02-22 |
2003-03-18 |
Skyepharma Canada Inc. |
Fibrate-statin combinations with reduced fed-fasted effects
|
US6984395B2
(en)
*
|
2001-04-11 |
2006-01-10 |
Qlt, Inc. |
Drug delivery system for hydrophobic drugs
|
MXPA03010549A
(es)
*
|
2001-05-18 |
2004-05-27 |
Ranbaxy Lab Ltd |
Formas de dosificacion de oxcarbazepina.
|
GB0208742D0
(en)
|
2002-04-17 |
2002-05-29 |
Bradford Particle Design Ltd |
Particulate materials
|
US6746635B2
(en)
*
|
2001-08-08 |
2004-06-08 |
Brown University Research Foundation |
Methods for micronization of hydrophobic drugs
|
US20030054042A1
(en)
*
|
2001-09-14 |
2003-03-20 |
Elaine Liversidge |
Stabilization of chemical compounds using nanoparticulate formulations
|
US20060003012A9
(en)
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
EP1429749A2
(de)
|
2001-09-26 |
2004-06-23 |
Baxter International Inc. |
Herstellung von nanopartikeln im submikrometerbereich durch dispersion und entzug des lösungsmittels oder der flüssigen phase
|
US6878693B2
(en)
*
|
2001-09-28 |
2005-04-12 |
Solubest Ltd. |
Hydrophilic complexes of lipophilic materials and an apparatus and method for their production
|
US20050227911A1
(en)
*
|
2001-09-28 |
2005-10-13 |
Solubest Ltd. |
Hydrophilic dispersions of nanoparticles of inclusion complexes of macromolecules
|
US20050233003A1
(en)
*
|
2001-09-28 |
2005-10-20 |
Solubest Ltd. |
Hydrophilic dispersions of nanoparticles of inclusion complexes of salicylic acid
|
US8663687B2
(en)
*
|
2001-10-12 |
2014-03-04 |
Monosol Rx, Llc |
Film compositions for delivery of actives
|
US7112340B2
(en)
*
|
2001-10-19 |
2006-09-26 |
Baxter International Inc. |
Compositions of and method for preparing stable particles in a frozen aqueous matrix
|
DE60213842T2
(de)
|
2001-10-30 |
2007-09-06 |
Novartis Ag |
Staurosporin-derivate als hemmer der flt3-rezeptor-tyrosinkinase-wirkung
|
EP1465590B1
(de)
*
|
2001-11-02 |
2008-03-26 |
The Governors Of The University Of Alberta |
Micelle-zusammensetzungen enthaltend pegylierten phospholipide und einen photosensibilisator
|
US7700851B2
(en)
*
|
2001-11-13 |
2010-04-20 |
U.S. Smokeless Tobacco Company |
Tobacco nicotine demethylase genomic clone and uses thereof
|
GB0127832D0
(en)
*
|
2001-11-20 |
2002-01-09 |
Jagotec Ag |
Method for the preparation of pharmaceutical nanosuspensions
|
ES2364636T3
(es)
|
2001-12-19 |
2011-09-08 |
Novartis Ag |
Administración pulmonar de aminoglucósidos.
|
US20030129242A1
(en)
*
|
2002-01-04 |
2003-07-10 |
Bosch H. William |
Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer
|
EP1471887B1
(de)
|
2002-02-04 |
2010-04-21 |
Elan Pharma International Ltd. |
Arzneistoffnanopartikel mit lysozym-oberflächenstabilisator
|
US6861066B2
(en)
*
|
2002-03-11 |
2005-03-01 |
Health Plus International Inc. |
Method for the delivery of a biologically active agent
|
US20060280761A1
(en)
*
|
2002-03-11 |
2006-12-14 |
Health Plus International, Inc. |
Nanofluidized B-12 composition and process for treating pernicious anemia
|
US20080220075A1
(en)
*
|
2002-03-20 |
2008-09-11 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of angiogenesis inhibitors
|
DE60309300T3
(de)
*
|
2002-03-20 |
2011-02-24 |
Elan Pharma International Ltd. |
Nanopartikelzusammensetzungen von angiogeneseinhibitoren
|
WO2003088951A1
(en)
*
|
2002-04-15 |
2003-10-30 |
Eiffel Technologies Limited |
Formulation of fine particles using liquefied or dense gases
|
US7582284B2
(en)
*
|
2002-04-17 |
2009-09-01 |
Nektar Therapeutics |
Particulate materials
|
JP4533134B2
(ja)
*
|
2002-06-10 |
2010-09-01 |
エラン ファーマ インターナショナル,リミティド |
ナノ粒子ポリコサノール製剤および新規なポリコサノールの組合せ
|
US6998051B2
(en)
*
|
2002-07-03 |
2006-02-14 |
Ferro Corporation |
Particles from supercritical fluid extraction of emulsion
|
JP4776229B2
(ja)
*
|
2002-07-16 |
2011-09-21 |
エラン ファーマ インターナショナル,リミティド |
安定なナノ粒子活性物質の液体投与組成物
|
WO2004024123A1
(en)
*
|
2002-09-16 |
2004-03-25 |
Vasogen Ireland Limited |
Accelerating recovery from trauma
|
WO2004032980A1
(en)
*
|
2002-10-04 |
2004-04-22 |
Elan Pharma International Limited |
Gamma irradiation of solid nanoparticulate active agents
|
US6966990B2
(en)
|
2002-10-11 |
2005-11-22 |
Ferro Corporation |
Composite particles and method for preparing
|
CN1243538C
(zh)
*
|
2002-11-21 |
2006-03-01 |
武汉利元亨药物技术有限公司 |
熊果酸豆磷脂纳米粒冻干粉针及制备方法
|
WO2004052015A1
(ja)
*
|
2002-11-29 |
2004-06-17 |
Sony Corporation |
符号化装置およびその方法
|
WO2004052354A1
(ja)
*
|
2002-12-06 |
2004-06-24 |
Otsuka Pharmaceutical Factory, Inc. |
プロポフォール含有脂肪乳剤
|
GB0302673D0
(en)
|
2003-02-06 |
2003-03-12 |
Astrazeneca Ab |
Pharmaceutical formulations
|
US6931888B2
(en)
|
2003-02-07 |
2005-08-23 |
Ferro Corporation |
Lyophilization method and apparatus for producing particles
|
US7083748B2
(en)
*
|
2003-02-07 |
2006-08-01 |
Ferro Corporation |
Method and apparatus for continuous particle production using supercritical fluid
|
JP2004323444A
(ja)
*
|
2003-04-25 |
2004-11-18 |
Hamamatsu Kagaku Gijutsu Kenkyu Shinkokai |
凍結乾燥微粒子製剤およびその製法
|
US20060008531A1
(en)
*
|
2003-05-08 |
2006-01-12 |
Ferro Corporation |
Method for producing solid-lipid composite drug particles
|
US7842232B2
(en)
*
|
2003-05-22 |
2010-11-30 |
Elan Pharma International, Ltd. |
Sterilization of dispersions of nanoparticulate active agents with gamma radiation
|
GB0319797D0
(en)
*
|
2003-08-26 |
2003-09-24 |
Leuven K U Res & Dev |
Particle size reduction of poorly soluble drugs
|
MXPA06007829A
(es)
*
|
2004-01-08 |
2006-09-01 |
Wyeth Corp |
Composicion farmaceutica directamente comprimible para la administracion oral de 42-ester de rapamicina con acido 3-hidroxi-2-(hidroximetil)-2-metilpropionico.
|
NZ589967A
(en)
*
|
2004-01-14 |
2012-07-27 |
Gilead Sciences Inc |
Lipid-based dispersions useful for drug delivery
|
US20050170063A1
(en)
*
|
2004-01-29 |
2005-08-04 |
Lalit Chordia |
Production of powder and viscous material
|
US20050196416A1
(en)
*
|
2004-02-05 |
2005-09-08 |
Kipp James E. |
Dispersions prepared by use of self-stabilizing agents
|
US8216610B2
(en)
*
|
2004-05-28 |
2012-07-10 |
Imaginot Pty Ltd. |
Oral paracetamol formulations
|
AU2005247048B2
(en)
*
|
2004-05-28 |
2007-12-13 |
Imaginot Pty Ltd |
Oral therapeutic compound delivery system
|
WO2006026592A2
(en)
*
|
2004-08-27 |
2006-03-09 |
Spherics, Inc. |
Oral administration of poorly absorbed drugs, methods and compositions related thereto
|
WO2006026504A2
(en)
*
|
2004-08-27 |
2006-03-09 |
Spherics, Inc. |
Mucoadhesive oral formulations of high permeability, high solubility drugs
|
US20080171687A1
(en)
*
|
2004-09-16 |
2008-07-17 |
Abraxis Bioscience, Inc. |
Compositions And Methods For The Preparation And Administration Of Poorly Water Soluble Drugs
|
US20060183766A1
(en)
*
|
2005-02-15 |
2006-08-17 |
Wyeth |
Orally bioavailable CCI-779 formulations
|
ES2338039T3
(es)
*
|
2005-04-13 |
2010-05-03 |
ABBOTT GMBH & CO. KG |
Procedimiento para la obtencion cuidadosa de supensiones de particulas de elevada finura y particulas de elevada finura, asi como su aplicacion.
|
US20060280787A1
(en)
*
|
2005-06-14 |
2006-12-14 |
Baxter International Inc. |
Pharmaceutical formulation of the tubulin inhibitor indibulin for oral administration with improved pharmacokinetic properties, and process for the manufacture thereof
|
BRPI0612071A2
(pt)
*
|
2005-06-14 |
2010-10-19 |
Baxter Int |
formulações farmacêuticas para minimizar interações entre fármacos
|
CN101309669A
(zh)
*
|
2005-11-15 |
2008-11-19 |
巴克斯特国际公司 |
脂氧合酶抑制剂的组合物
|
WO2007059591A1
(en)
|
2005-11-28 |
2007-05-31 |
Imaginot Pty Ltd |
Oral therapeutic compound delivery system
|
US7703698B2
(en)
*
|
2006-09-08 |
2010-04-27 |
Kimberly-Clark Worldwide, Inc. |
Ultrasonic liquid treatment chamber and continuous flow mixing system
|
US7810743B2
(en)
|
2006-01-23 |
2010-10-12 |
Kimberly-Clark Worldwide, Inc. |
Ultrasonic liquid delivery device
|
KR100919731B1
(ko)
*
|
2006-05-11 |
2009-09-29 |
재단법인서울대학교산학협력재단 |
안정제로서 폴리에테르를 함유한 백신전달용 키토산미립자
|
US8034286B2
(en)
*
|
2006-09-08 |
2011-10-11 |
Kimberly-Clark Worldwide, Inc. |
Ultrasonic treatment system for separating compounds from aqueous effluent
|
US9283188B2
(en)
*
|
2006-09-08 |
2016-03-15 |
Kimberly-Clark Worldwide, Inc. |
Delivery systems for delivering functional compounds to substrates and processes of using the same
|
US20100068251A1
(en)
*
|
2006-10-10 |
2010-03-18 |
Jina Pharmaceuticals, Inc. |
Aqueous Systems For The Preparation Of Lipid Based Pharmaceutical Compounds; Compositions, Methods, And Uses Thereof
|
WO2008080047A2
(en)
*
|
2006-12-23 |
2008-07-03 |
Baxter International Inc. |
Magnetic separation of fine particles from compositions
|
US7673516B2
(en)
*
|
2006-12-28 |
2010-03-09 |
Kimberly-Clark Worldwide, Inc. |
Ultrasonic liquid treatment system
|
US7712353B2
(en)
|
2006-12-28 |
2010-05-11 |
Kimberly-Clark Worldwide, Inc. |
Ultrasonic liquid treatment system
|
ES2538082T3
(es)
|
2007-02-11 |
2015-06-17 |
Map Pharmaceuticals Inc |
Método de administración terapéutica de DHE para permitir el rápido alivio de migraña mientras que se minimiza el perfil de efectos secundarios
|
WO2008099615A1
(ja)
|
2007-02-16 |
2008-08-21 |
Aska Pharmaceutical Co., Ltd. |
微粒子油性懸濁液を含む医薬組成物
|
US8426467B2
(en)
|
2007-05-22 |
2013-04-23 |
Baxter International Inc. |
Colored esmolol concentrate
|
US20080293814A1
(en)
*
|
2007-05-22 |
2008-11-27 |
Deepak Tiwari |
Concentrate esmolol
|
US8722736B2
(en)
|
2007-05-22 |
2014-05-13 |
Baxter International Inc. |
Multi-dose concentrate esmolol with benzyl alcohol
|
US7785674B2
(en)
*
|
2007-07-12 |
2010-08-31 |
Kimberly-Clark Worldwide, Inc. |
Delivery systems for delivering functional compounds to substrates and processes of using the same
|
US7947184B2
(en)
*
|
2007-07-12 |
2011-05-24 |
Kimberly-Clark Worldwide, Inc. |
Treatment chamber for separating compounds from aqueous effluent
|
US7998322B2
(en)
*
|
2007-07-12 |
2011-08-16 |
Kimberly-Clark Worldwide, Inc. |
Ultrasonic treatment chamber having electrode properties
|
US8454889B2
(en)
|
2007-12-21 |
2013-06-04 |
Kimberly-Clark Worldwide, Inc. |
Gas treatment system
|
US8858892B2
(en)
|
2007-12-21 |
2014-10-14 |
Kimberly-Clark Worldwide, Inc. |
Liquid treatment system
|
US8632613B2
(en)
|
2007-12-27 |
2014-01-21 |
Kimberly-Clark Worldwide, Inc. |
Process for applying one or more treatment agents to a textile web
|
US9421504B2
(en)
|
2007-12-28 |
2016-08-23 |
Kimberly-Clark Worldwide, Inc. |
Ultrasonic treatment chamber for preparing emulsions
|
US8215822B2
(en)
*
|
2007-12-28 |
2012-07-10 |
Kimberly-Clark Worldwide, Inc. |
Ultrasonic treatment chamber for preparing antimicrobial formulations
|
US20090166177A1
(en)
|
2007-12-28 |
2009-07-02 |
Kimberly-Clark Worldwide, Inc. |
Ultrasonic treatment chamber for preparing emulsions
|
US8206024B2
(en)
|
2007-12-28 |
2012-06-26 |
Kimberly-Clark Worldwide, Inc. |
Ultrasonic treatment chamber for particle dispersion into formulations
|
US8057573B2
(en)
|
2007-12-28 |
2011-11-15 |
Kimberly-Clark Worldwide, Inc. |
Ultrasonic treatment chamber for increasing the shelf life of formulations
|
GB0803969D0
(en)
*
|
2008-03-04 |
2008-04-09 |
Britannia Pharmaceuticals Ltd |
Improved phospholipid and method for its production
|
US20090311335A1
(en)
*
|
2008-06-12 |
2009-12-17 |
Scott Jenkins |
Combination of a triptan and an nsaid
|
GB0818403D0
(en)
*
|
2008-10-08 |
2008-11-12 |
Univ Leuven Kath |
Aqueous electrophoretic deposition
|
EP2334845A2
(de)
*
|
2008-10-06 |
2011-06-22 |
Katholieke Universiteit Leuven K.U. Leuven R&D |
Funktionelle schichten von biomolekülen und lebenden zellen und neues system zu ihrer herstellung
|
US8163388B2
(en)
|
2008-12-15 |
2012-04-24 |
Kimberly-Clark Worldwide, Inc. |
Compositions comprising metal-modified silica nanoparticles
|
US8685178B2
(en)
|
2008-12-15 |
2014-04-01 |
Kimberly-Clark Worldwide, Inc. |
Methods of preparing metal-modified silica nanoparticles
|
US11304960B2
(en)
|
2009-01-08 |
2022-04-19 |
Chandrashekar Giliyar |
Steroidal compositions
|
EP2266546A1
(de)
|
2009-06-08 |
2010-12-29 |
Advancell Advanced in Vitro Cell Technologies,S.A. |
Verfahren zur Herstellung kolloidaler Systeme zur Abgabe von Wirkstoffen
|
IT1398857B1
(it)
|
2009-06-10 |
2013-03-21 |
Univ Padova |
Coniugati polimerici fosfolipidi
|
FR2949063B1
(fr)
*
|
2009-08-11 |
2011-09-30 |
Pf Medicament |
Composition pharmaceutique comprenant un ester de dha destinee a etre administree par voie parenterale
|
EP2498753B1
(de)
*
|
2009-11-10 |
2019-03-06 |
Celgene Corporation |
Nanosuspension eines schlechtlöslichen arzneistoffs hergestellt über einen mikrofluidisierungsprozess
|
KR20120104316A
(ko)
*
|
2009-12-10 |
2012-09-20 |
메르크 파텐트 게엠베하 |
올리고펩티드, 바람직하게는 실렌기티드를 포함하는 약학 조성물
|
KR102183455B1
(ko)
*
|
2010-04-16 |
2020-11-26 |
산에이겐 에후.에후. 아이. 가부시키가이샤 |
쿠르쿠민 풍미의 마스킹 방법
|
AU2011320159B2
(en)
*
|
2010-10-29 |
2016-12-22 |
Western University Of Health Sciences |
Ternary mixture formulations
|
US9034858B2
(en)
|
2010-11-30 |
2015-05-19 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US20180153904A1
(en)
|
2010-11-30 |
2018-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US9358241B2
(en)
|
2010-11-30 |
2016-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US20120148675A1
(en)
|
2010-12-10 |
2012-06-14 |
Basawaraj Chickmath |
Testosterone undecanoate compositions
|
FI3156056T3
(fi)
|
2011-03-18 |
2024-03-01 |
Alkermes Pharma Ireland Ltd |
Sorbitaaniestereitä käsittäviä farmaseuttisia koostumuksia
|
WO2013066735A1
(en)
*
|
2011-10-31 |
2013-05-10 |
Merck Sharp & Dohme Corp. |
Nano-suspension process
|
JP6219918B2
(ja)
*
|
2012-03-19 |
2017-10-25 |
アルカームス ファーマ アイルランド リミテッド |
グリセロールエステルを含む医薬組成物
|
AU2013235526B2
(en)
|
2012-03-19 |
2017-11-30 |
Alkermes Pharma Ireland Limited |
Pharmaceutical compositions comprising benzyl alcohol
|
NZ630643A
(en)
|
2012-03-19 |
2017-08-25 |
Alkermes Pharma Ireland Ltd |
Pharmaceutical compositions comprising fatty acid esters
|
JP6654042B2
(ja)
|
2012-09-19 |
2020-02-26 |
アルカームス ファーマ アイルランド リミテッド |
貯蔵安定性が改善された医薬組成物
|
US9603756B2
(en)
*
|
2013-11-07 |
2017-03-28 |
Unicharm Corporation |
Composite material for absorbent article, and method for manufacturing thereof
|
WO2015143145A1
(en)
|
2014-03-20 |
2015-09-24 |
Alkermes Pharma Ireland Limited |
Aripiprazole formulations having increased injection speeds
|
US20170246187A1
(en)
|
2014-08-28 |
2017-08-31 |
Lipocine Inc. |
(17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
|
US9498485B2
(en)
|
2014-08-28 |
2016-11-22 |
Lipocine Inc. |
Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
|
TW201613888A
(en)
*
|
2014-09-26 |
2016-04-16 |
Helsinn Healthcare Sa |
Crystalline forms of an NK-1 antagonist
|
RU2737893C2
(ru)
*
|
2015-08-11 |
2020-12-04 |
Айсью Медсинз Б.В. |
Пэгилированная липидная наночастица с биоактивным липофильным соединением
|
US20170320862A1
(en)
|
2016-05-03 |
2017-11-09 |
Cadila Healthcare Limited |
Process for the preparation of brexpiprazole and intermediates thereof
|
EP3544614A4
(de)
|
2016-11-28 |
2020-08-05 |
Lipocine Inc. |
Orale testosteron-undecanoat-therapie
|
CN107875436B
(zh)
*
|
2017-11-10 |
2020-02-18 |
杭州华微医疗科技有限公司 |
一种负载碳酸氢钠粉末的液体栓塞剂组合物及其应用
|
JP7384812B2
(ja)
|
2018-03-05 |
2023-11-21 |
アルカームス ファーマ アイルランド リミテッド |
アリピプラゾール投与戦略
|
CN109091451B
(zh)
*
|
2018-09-10 |
2021-08-13 |
武汉百纳礼康生物制药有限公司 |
亲水性药物的油相液晶凝胶前体制剂及其制备方法
|
EP4056038A1
(de)
*
|
2021-03-10 |
2022-09-14 |
Basf Se |
Wirkstoffhaltige mikrokapseln
|